Call Buying Activity in Atlassian (TEAM) Targets 6% Upside in Shares into November -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Atlassian Corporation (TEAM) PT Lowered to $206 at Goldman Sachs, Following Earnings
October 30, 2020 11:20 AM EDTGoldman Sachs analyst Heather Bellini lowered the price target on Atlassian Corporation (NASDAQ: TEAM) to $206.00 (from $209.00) while maintaining a Buy rating.
... MorePre-Open Stock Movers 10/30: (EQ) (TRUP) (PLT) Higher; (AXGT) (COLM) (TWTR) Lower (more...)
October 30, 2020 9:29 AM EDTPre-Open Stock Movers:
Axovant Gene Therapies Ltd. (Nasdaq: AXGT) 39.5% LOWER; announced program updates to be presented as part of its virtual R&D Day on Friday, October 30, 2020 at 11:30 AM Eastern time, for the Companys AXO-Lenti-PD gene therapy for Parkinsons disease. Trial pushed back.
Columbia Sportswear (NASDAQ: COLM) 16.4% LOWER; reported Q3 EPS of $0.94, $0.22 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $701.1 million versus the consensus estimate of $767.13 million. Columbia Sportswear sees Q4 2020 EPS... More
Atlassian Corporation (TEAM) PT Raised to $243 at Citi
October 30, 2020 6:13 AM EDTCiti analyst Walter Pritchard raised the price target on Atlassian Corporation (NASDAQ: TEAM) to $243.00 (from $241.00) while maintaining a Buy rating.... More
Truist Securities Downgrades Atlassian Corporation (TEAM) to Hold
October 30, 2020 6:10 AM EDTTruist Securities downgraded Atlassian Corporation (NASDAQ: TEAM) from Buy to Hold.
For an analyst ratings summary and ratings history on Atlassian Corporation click here. For more ratings news on Atlassian Corporation click here.
Shares of Atlassian Corporation closed at $199.00 yesterday.
... MoreAfter-Hours Stock Movers 10/29: (EQ) (PLT) (GOOGL) Higher; (AXGT) (COLM) (TWTR) (AAPL) Lower (more...)
October 29, 2020 6:01 PM EDTAfter-Hours Stock Movers:
Axovant Gene Therapies Ltd. (Nasdaq: AXGT) 39.5% LOWER; announced program updates to be presented as part of its virtual R&D Day on Friday, October 30, 2020 at 11:30 AM Eastern time, for the Companys AXO-Lenti-PD gene therapy for Parkinsons disease. Trial pushed back.
Columbia Sportswear (NASDAQ: COLM) 16.4% LOWER; reported Q3 EPS of $0.94, $0.22 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $701.1 million versus the consensus estimate of $767.13 million. Columbia Sportswear sees Q4 2020 EPS of $1.07-$1.32,... More
Atlassian (TEAM) Tops Q1 EPS by 3c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Below Consensus
October 29, 2020 4:16 PM EDTAtlassian (NASDAQ: TEAM) reported Q1 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. Revenue for the quarter came in at $459.5 million versus the consensus estimate of $440.41 million.
We drove strong results in Q1, generating $460 million in revenue, growth of 26% from the prior year, said Scott Farquhar, Atlassians co-founder and co-CEO. We also added more than 8,600 net new customers during the quarter, and now serve over 182,000 customers, including more than 160,000 using our cloud products, as we take the... More
